Lung Cancer
Volume 55, Issue 1 , Pages 123-124 , January 2007

PET/CT imaging in response evaluation of SCLC patients

Received 3 September 2006

References 

  1. Fischer BM, Mortensen J, Langer SW, Loft A, Berthelsen AK, Daugaard G, et al. PET/CT imaging in response evaluation of patients with small cell lung cancer. Lung Cancer. 2006;54:41–49
  2. Hebert ME, Lowe VJ, Hoffman JM, Patz EF, Anscher MS. Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: preliminary findings. Am J Clin Oncol. 1996;19:416–421
  3. Ryu JS, Noah C, Choi NC, Fischman AJ, Lynch TJ, Mathisen DJ. FDG–PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology. Lung Cancer. 2002;35:179–187
  4. Ishimori T, Saga T, Nagata Y, Nakamoto Y, Higashi T, Mamede M, et al. 18F-FDG and 11C-methionine PET for evaluation of treatment response of lung cancer after stereotactic radiotherapy. Ann Nucl Med. 2004;18:669–674
  5. Gagel B, Reinartz P, Demirel C, Kaiser HJ, Zimny M, Piroth M, et al. [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: a feasibility study. BMC Cancer. 2006;6:51–58

PII: S0169-5002(06)00524-1

doi: 10.1016/j.lungcan.2006.09.016

Lung Cancer
Volume 55, Issue 1 , Pages 123-124 , January 2007

Article Tools